Showing 21 - 30 of 1,962
Persistent link: https://www.econbiz.de/10001831516
In this study we try to evaluate some of the redistributive aspects of public drug plan for seniors by examining the effects on out-of-pocket expenditures of such drug plan in Canada.
Persistent link: https://www.econbiz.de/10004971422
The question as to how society should support pharmaceutical (‘pharma’) innovation is both pertinent and timely: Pharma drugs are an integral component of modern health care and hold the promise to treat more effectively various debilitating health problems. The productivity of the pharma...
Persistent link: https://www.econbiz.de/10005013021
The question as to how society should support pharmaceutical (‘pharma’) innovation is both pertinent and timely: Pharma drugs are an integral component of modern health care and hold the promise to treat more effectively various debilitating health problems. The rate of pharma innovation,...
Persistent link: https://www.econbiz.de/10005051492
Health scientists often use observational data to estimate treatment effects when controlled experiments are not feasible. A limitation of observational research is non-random selection of subjects into different treatments, potentially leading to selection bias. The 2 commonly used solutions to...
Persistent link: https://www.econbiz.de/10005181073
The 1984 Canada Health Act does not require that the provinces subsidize prescription drugs. Many provinces do, however, provide categorical coverage to the elderly, social assistance recipients and others, although the generosity of coverage is highly variable. A system of parallel private...
Persistent link: https://www.econbiz.de/10005181125
This paper examines how the use of ‘authorized-generics’ (AGs) influences Canadian prescription drug prices. An authorized-generic is the actual brand name drug product, manufactured by the brand firm, but sold as a generic by a licensee or subsidiary of the brand, competing with independent...
Persistent link: https://www.econbiz.de/10005404411
Background The Health Utilities Index Mark 3 (HUI3) is a comprehensive, compact health status classification and health state preference system. The HUI3 system has been implemented in 4 Canadian population health surveys. Objectives To evaluate the construct validity of the HUI3 for the...
Persistent link: https://www.econbiz.de/10005405468
Several studies suggest that, on the basis of life expectancy (LE) regressions, new pharmaceutical drugs are responsible for some of the marked gains in LE observed over the last 50 years. We critically appraise these studies. We point out several modeling issues, including disentangling the...
Persistent link: https://www.econbiz.de/10005635177
This paper presents new homogeneous series on top shares of income from 1920 to 2000 in Canada using personal income tax return data. Top income shares display a U-shaped pattern over the century, with a precipitous drop during World War II, followed by a slower decline until 1970. Since the...
Persistent link: https://www.econbiz.de/10005763274